AI assistant
Marksans Pharma Ltd. Board/Management Information 2023
62142_rns_2023-05-30_8bbe94d3-f809-4a00-8db3-44374b55f2e7.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Date: 30th May, 2023
BSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404
National Stock Exchange of India Limited Listing Department Exchange Plaza, C-1, Block-G, Bandra- Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS
Sub: Outcome of Board Meeting
Dear Sir,
This is to inform you that the Board of Directors of the Company, at its meeting held today i.e. Monday, 30 thMay, 2022 at Mumbai, has approved the following:
-
Audited Financial Results for the quarter and financial year ended 31st March, 2023 Audited Financial Results (both Standalone and Consolidated) for the quarter and financial year ended 31st March, 2023 have been approved by the Board of Directors along with Auditors Report thereon.
-
Declaration of Dividend for financial year 2022-23
Declaration of dividend @ Re. 0.50 (Rupee Zero and Paise Fifty) i.e. 50% per equity share ofRe. 1/- each face value for the financial year 2022-23 have been approved by the Board of Directors. The payment of the dividend shall be made on or after 12th June, 2023 to all the members of the Company whose names has been entered on Record Date i.e 7thJune, 2023.
- Appointment ofIndependent Director
Based on the recommendation of the Nomination and Remuneration Committee, Ms. Shailaja Vardhan (DIN: 10172764) has been appointed as an Additional Director (Non-Executive, Independent), for a term of 5 years effective from 30th May, 2023 subject to the approval of the members of the Company and her office shall not be liable to retire by rotation.
Further, Ms. Vardhan is not debarred from holding the office of Director by virtue of any Order passed by the Securities and Exchange Board of India or any other such authority.
Details required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular CIRJCFD/CMD/4/2015 dated September 09, 2015 is enclosed as Annexure 1. /f2,. I
~k-rksanSPharma.com
~. ••• 1...:4
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • Fax: +91-224001 2011 E-mail: [email protected]
- Resignation of Ms. Meena Rani Surana (DIN: 08863769) as an Independent Director On receipt of the resignation letter tendered by Ms. Meena Rani Surana (DIN: 08863769), the Board noted her resignation as an Independent Director of the Company with effect from May 30, 2023.
The Resignation letter along with requisite disclosure as required under Regulation 30 of Listing Regulations read with Clause 7B of Part A of Schedule III of the Listing Regulations and SEBI Circular CIRlCFD/CMD/4/2015 dated September 09, 2015 is enclosed as Annexure II.
The meeting commenced at \ 2-: t) 0 'M and concluded at 61 : VI ~ P fVJ •
You are requested to note the above in your records.
Thanking You.
Yours faithfully, For Marksans Pharma Limited
Harshavardhan Panigrahi Company Secretary
Ene!. As Above
CIN : L24110MH1992PLC066364 www.marksanspharma.com
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • Fax: +91-224001 2011 E-mail: [email protected]
Annexure I
Details pertaining to the appointment of Ms. Shailaja Vardhan as an Additional Director (Non-Executive, Independent) of Marksans Pharma Limited is given below:
| Sr. No | Particulars | Details |
|---|---|---|
| I. | Name of Independent Director |
Ms. Shailaja Vardhan (DIN: 10172764) |
| 2. | Reason for Change viz., appointment, resignation, removal, death or otherwise |
Appointed as Additional Director (Non-Executive, Independent) |
| & Date of Appointment term of appointment |
Ms. Shailaja Vardhan has been appointed as an Additional Director (Non-Executive, Independent), for a term of 5 years effective from 31st May, 2023 subject to the approval of the members of the Company and her office shall not be liable to retire by rotation. |
|
| 3. | Brief Profile: | Mr. Shailaja Vardhan has done her management programme from IHMCT & AN. She has over 30 years of experience in the field of corporate communications, corporate public communications, building brand architecture, positioning go-to-market strategies, CSR activities, etc. She is also into strategic role the 111 development of compelling marketing communication. |
| Driven by a passion for Corporate Social Responsibility, she has worked with the Confederation of Indian Industry (CIl) to assist PaniyurPeriyaKuppam, a Tsunami-affected village Tamil Nadu with Ford India. Under her 111 leadership at Ogilvy, the team received the prestigious WPP award for the WHO program aimed at eliminating Lymphatic Filariasis from 13 districts in Tamil Nadu. |
||
| Presently, she head of corporate IS communications at Apollo Hospitals group. Before that she has worked with MARG Ltd., Ford India, Ogilvy, etc. |
||
| 4. | Disclosure of relationships between directors |
There are no inter-se relations between Ms. Shailaja Vardhan and the other members of the Board. |
Petuk ~.!!larkSanspharma.com ,r'
Annexure II
Details pertaining to the resignation of Ms. Meena Rani Surana as an Independent Director of Marksans Pharma Limited is given below:
| Sr. No | Particulars | Details |
|---|---|---|
| I. | Name of Independent Director |
Ms. Meena Rani Surana (DIN: 08863769) |
| 2. | Reason for Change viz., appointment, resignation, removal, death or otherwise |
Resignation |
| 3. | Reason for Resignation: |
Personal reasons |
| 4. | Effective Date of resignation |
30th May, 2023 |
| 5. | Brief profile (in case of appointment) |
Not Applicable |
| 6. | Confirmation from the Independent Director |
Ms. Meena Rani Surana has confirmed that there are no other material reasons other than the reason mentioned above, for her resignation as Independent Director of Marksans Pharma Limited. |
| 7. | Names of the listed entities in which Ms. Meena Rani Surana holds directorships, indicating the category of directorship and membership of board committees, ifany. |
None |
CIN : L24110MH1992PLC066364
www.marksanspharma.com
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • Fax: +91-224001 2011 E-mail: [email protected]
[email protected]
From: Sent: To: Subject:
Meena Rani meenarani08@gmail.com 29 May 2023 19:19 harshavardhan Resignation as an Independent Director
To the Board of Directors
Marksans Pharma Limited
Mumbai, India
Dear Sir/Madam,
Due to personal reasons, I [Dr. Meena Rani Surana (DIN: 08863769)] hereby resign as an Independent Director in Marksans Pharma Limited effective from May 30, 2023. I confirm that there are no other material reasons other than the reason mentioned here, for my resignation as an Independent Director of Marksans Pharma Limited.
With Best Regards,
Dr. Meena Rani Surana